Article
Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability.
European journal of clinical pharmacology - 1 Jun 2021
Oliveira-Paula Gustavo H, Coeli-Lacchini Fernanda Borchers, Ferezin Letícia Perticarrara, Ferreira Graziele C, Pinheiro Lucas C, Paula-Garcia Waynice N, Garcia Luis V, Tanus-Santos Jose E, Lacchini Riccardo
Abstract excerpt
PURPOSE: Propofol anesthesia is usually accompanied by hypotensive responses, which are at least in part mediated by nitric oxide (NO). Arginase I (ARG1) and arginase II (ARG2) compete with NO synthases for their common substrate L-arginine, therefore influencing the NO formation. We examined here whether ARG1 and ARG2 genotypes and haplotypes affect the changes in blood pressure and NO bioavailability in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
